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Abstract
Background: Obesity is a major public health problem in both developed and developing countries alike and
leads to a series of changes in respiratory physiology. There is a strong correlation between obesity and
cardiopulmonary sleep disorders. Weight loss among such patients leads to a reduction in these alterations in
respiratory physiology, but clinical treatment is not effective for a long period of time. Thus, bariatric surgery is a
viable option.
Methods/Design: The present study involves patients with morbid obesity (BMI of 40 kg/m
2 or 35 kg/m
2 to 39.9
kg/m
2 with comorbidities), candidates for bariatric surgery, screened at the Santa Casa de Misericórdia Hospital in
the city of Sao Paulo (Brazil). The inclusion criteria are grade III morbid obesity, an indication for bariatric surgery,
agreement to participate in the study and a signed term of informed consent. The exclusion criteria are BMI above
55 kg/m
2, clinically significant or unstable mental health concerns, an unrealistic postoperative target weight and/
or unrealistic expectations of surgical treatment. Bariatric surgery candidates who meet the inclusion criteria will be
referred to Santa Casa de Misericórdia Hospital and will be reviewed again 30, 90 and 360 days following surgery.
Data collection will involve patient records, personal data collection, objective assessment of HR, BP, neck
circumference, chest and abdomen, collection and analysis of clinical preoperative findings, polysomnography,
pulmonary function test and a questionnaire on sleepiness.
Discussion: This paper describes a randomised controlled trial of morbidly obese patients. Polysomnography,
respiratory mechanics, chemosensitive response and quality of life will be assessed in patients undergoing or not
undergoing bariatric surgery.
Trial Registration: The protocol for this study is registered with the Brazilian Registry of Clinical Trials - ReBEC
(RBR-9k9hhv).
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Obesity is currently one of the most serious public
health problems. The prevalence of this condition has
grown in an accentuated fashion in recent decades, even
in developing countries, leading to a global epidemic.
Over 1.6 billion adults worldwide are overweight, among
which 400 million are obese. The World Health Organi-
sation predicts that 10% of the global population will be
obese by 2015 [1]. As poverty has been undergoing a
process of eradication, obesity has become a more fre-
quent and more serious problem than malnutrition
[2,3]. In adults, overweight is characterised by a body
mass index (BMI) between 25 kg/m
2 and 29.9 kg/m
2
and obesity is defined beginning at 30 kg/m
2 [4].
When excess weight reaches very high values (BMI ≥
40 kg/m
2), obesity is considered a severe dysfunction
due to the association with diseases that are either
caused or aggravated by this condition, corresponding
to grade III obesity, which is also denominated morbid
obesity [4]. The most frequent comorbidities are sys-
temic arterial hypertension [5,6], type II diabetes melli-
tus [7], obstructive sleep apnoea [8], degenerative joint
disease [9], dyslipidemia, coronary disease [10,11],
respiratory dysfunction [12] and psychosocial problems
[13].
Obesity is the most important risk factor for obstruc-
tive sleep apnoea (OSA), especially with fat build-up in
the upper portion of the abdomen and the neck region.
At least 60 to 70% of patients with OSA are obese [14].
Moreover, the incidence among patients with Grade III
obesity is 12-fold to 30-fold greater than that in the gen-
eral population [15,16]. OSA is characterised by recur-
rent episodes of partial or complete obstruction of the
upper airway during sleep in the presence of ventilatory
effort, with a consequent drop in oxyhemoglobin satura-
tion, generating negative intrathoracic pressure and
arousals [17]. The gold standard for the diagnosis of
OSA is basal nocturnal polysomnography (PSG), which
is the simultaneous recording of physiological para-
meters during a night of sleep, involving the analysis of
sleep stages, breathing pattern, cardiovascular function
and body movements [18,19].
The association between obesity and respiratory sleep
disorders was first described in 1918 by William Osler,
who was reminded of a Charles Dickens’ characters
nicknamed “John, the fat boy”, a plethoric snorer and
terribly sleepy [20]. The treatment of obesity in these
patients has since become a priority [21]. Common dis-
eases such as obesity and hypertension should not be
analysed without considering respiratory sleep disorder
as a possible causal factor. In recent years, the preva-
lence of such disorders has grown, affecting 40% of the
general population [22,23].
The aim of the treatment of obesity is to improve
both health and quality of life through enough of a
reduction in body weight to eliminate or improve
comorbidities and promote psychological wellbeing [24].
Medical management of obesity is routinely the first line
of treatment prescribed by physicians and lay persons
alike. Medical therapy often involves a combination of
calorie restriction, behaviour modification, increased
exercise and pharmacotherapy. Behaviour modification
in the treatment regimen may help slow the tendency
toward weight regain, but does not prevent it entirely.
Unfortunately, the medical treatment of morbid obesity
provides minimal sustained weight loss in the majority
of patients [25,26]. The fact that morbid obesity remains
largely refractory to dietary and medication therapy
makes bariatric surgery a viable option [27].
Patients with a BMI of greater than 40 Kg/m
2 or 35 to
39.9 Kg/m
2 and associated to comorbidities are candi-
dates for bariatric surgery. The most often employed
surgical methods are divided into three groups: restric-
tive, malabsorptive and mixed [28,29]. The most com-
mon techniques are Fobi-Capella surgery and
Scopinaro’s biliopancreatic diversion, which are mixed
techniques [30].
This study will sleep study, respiratory mechanics,
chemosensitive response and quality of life in morbidly
obese patients undergoing bariatric surgery.
Aims and hypotheses
The aims of this study are to assess the evolution of pul-
monary function through spirometry, ventilatory
mechanics and breathing tests as well as sleep study
parameters and quality of life in subjects suffering from
morbid obesity undergoing bariatric surgery and deter-
mine a possible correlation between weight loss and
these physiological variables. We hypothesise that the
weight loss induced by surgical intervention reduces the
impact of this disease on sleep quality, cardiovascular
consequences and quality of life as well as financial
expenditures on treatment.
Methods/design
Study design
The study design is a parallel-group randomised con-
trolled trial and is summarised in Figure 1, and is being
conducted according to the ethical standards established
in the 1961 Declaration of Helsinki (as revised in Hong
Kong in 1989 and in Edimburgh, Scotland in 2000).
This study is registered with the World Health Organi-
zation Universal Trial Number (UTN) U1111-1121-
8873, and Registro Brasileiro de Ensaios Clínicos (RBR-
9k9hhv), and has been approved by the Human
Research Ethics Committees of the Nove de Julho
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2009). All participants gave written, informed consent.
Subjects and recruitment procedure
Individuals with morbid obesity (BMI between 40 kg/
m
2 and 50 Kg/m
2) or BMI between 35 kg/m
2 and 39.9
kg/m
2 associated to comorbidities will be recruited
from the surgery ward of the Santa Casa de Misericór-
dia Hospital of the city of Sao Paulo (Brazil) and sent
to the Sleep Laboratory of the Universidade Nove de
Julho, Sao Paulo (Brazil). Participants will be recruited
consecutively and screened for eligibility using a
Figure 1 Flowchart representing the study design.
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described below.
Inclusion Criteria
1- Grade III morbid obesity (BMI ≥ 40 kg/m
2)o r≥
35 kg/m
2 with comorbidities;
2- Male and female patients aged 18 to 65 years;
3- Documented history of conventional weight loss
attempts having proven unsuccessful over time;
4- Agreement to participate in the study through a
signed term of informed consent.
Exclusion Criteria
1- Any medical condition rendering surgery too
risky;
2- BMI above 55 kg/m
2;
3- Clinically significant or unstable mental health
concerns;
4- Unrealistic postoperative target weight and/or
unrealistic expectations of surgical treatment;
5- Pregnancy, lactation or planned pregnancy within
two years of potential surgical treatment;
6- Lack of safe access to abdominal cavity or gastro-
intestinal tract;
7- Smoking (at least 8 weeks prior to surgery), abu-
sive alcohol use or drug use.
Randomisation
Following the initial evaluation and fulfilment of the
eligibility criteria, the subjects will be randomly dis-
tributed into an intervention group [bariatric surgery
group (BSG)] and control group (CG). Randomisation
numbers will be generated using a randomisation
table at a central office. A series of numbered, sealed,
opaque envelopes will be used to ensure confidential-
ity. Each envelope will contain a card stipulating to
which group the subject will be allocated. This rando-
misation criterion will be used due to the enormous
number of candidates for bariatric surgery and the
limited capacity of the surgical ward to meet this
demand. All subjects submitted to this randomisation
protocol will meet the eligibility criteria and will be
clinically stable.
Sample size
A previous study published by Lettieri et al. (2008) [31]
identified a mean reduction in the Apnoea-Hypnoea
Index of 23.4 events/hour in morbidly obese patients
submitted to bariatric surgery (expected size effect).
Using a standard deviation of 22.8 events/hour from the
same study and considering a = 0.05 and power = 80%,
the sample was estimated as 17 patients.
Study interventions
Evaluation
All evaluations will occur prior to the surgical interven-
tion. The patients submitted to bariatric surgery will be
evaluated again 30, 90 and 360 days following the proce-
dure. All subjects in both groups will be submitted to
the following evaluation protocol.
Clinical evaluation
General physical measurements and PSG will be per-
formed a week prior to preparation for the surgery by a
well-trained physician and physical therapist following
recommended procedures and using precise instruments
and will include body weight (kg), height (m), calcula-
tion of body mass index (BMI) using the formula
weight/height
2 [32], circumferences (cm) of the neck,
waist, and hip [33], heart and respiratory rates, blood
pressure values, Mallampati index [34], tonsil index [35],
the administration of specific questionnaires for sleep
apnoea and excessive daytime sleepiness [36] and a
quality of life questionnaire [37].
Educational and psychological program
During the initial evaluations, all patients will take part
in an educational program in the auditorium of Santa
Casa de Misericordia Hospital, where they will receive
information on the development and progression of
obesity, treatment (pharmacological and non-pharmaco-
logical) and the importance of regular physical activity
practice. All patients will receive a chart containing the
educational program [38].
Waist and neck circumference
The measurements of waist and neck circumference will
be performed with a metric tape (7 mm in width). The
sites of the measurements will be standardized. Waist
circumference will be measured at the mid point
between the lower edge of the last rib and the iliac
crest. Neck circumference will be measured horizontally
over the cricoid cartilage [39].
Thorax and abdomen cirtometry
Cervical thoracoabdominal cirtometry will be carried out
to assess thorax and abdomen mobility and define the
diaphragm index. The measurement will be performed
b yf i x i n gt h ez e r op o i n to nt h em e t r i ct a p et ot h ea n t e -
rior region of the thorax at the level that is being mea-
sured (axillary, xiphoid or abdominal), with the tape
enveloping the entire thorax or abdomen with maximal
possible pressure and the other extremity of the tape
placed over this same fixed point. The aim of the maxi-
mal possible pressure of the tape on the body is to
avoid the interference of soft structures in the measure-
ments. Mobility and range of motion are provided by
maximal inspiration and expiration [40].
Pulmonary function tests
Spirometry The lung function tests will be carried out
with the patient seated in a comfortable position using
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Louisville, CO, USA) and following guidelines for the
execution of pulmonary function tests of the Brazilian
Society of Pneumology [41] and the European Respira-
tory Society [42]. The subjects will perform the test
seated as comfortably as possible, with the body erect
and the upper limbs unsupported. All exams will be car-
ried out by a technician trained in obtaining the neces-
sary cooperation from the subjects and appropriately
operating the equipment in order to ensure accurate,
reproducible results. The equipment will be calibrated
prior to each exam with a 3-L syringe [41].
Analysis of respiratory mechanics Maximal inspira-
tory pressure (MIP) and maximal expiratory pressure
(MEP) physiologically constitute the most adequate test
for the determination of respiratory muscle strength.
MIP is an indicator of ventilatory capacity and the
development of respiratory failure and is indicated for
the assessment of the degree of abnormality and moni-
toring of the weakening of inspiratory muscles indivi-
dually in the progress of patients [43]. The tests will
occur on the same day in which the patients undergo
spirometry. The tests will be performed in a quiet set-
ting. The patients will be seated comfortably, with the
trunk at a 90-degree angle in relation to the thighs and
breathing calmly and at rest [41].
Rebreathing test In this study protocol, we will employ
the re-inhalation method described by Read [44]. This is
a simple technique that has been validated in the litera-
ture and allows the determination of the ventilatory
response to CO2 stimulus. The patients will breathe
through a mouthpiece and, after achieving a steady
state, basal ventilation will be recorded for three min-
utes. The patients will then breathe connected to a 15-L
latex balloon filled with a 7% CO2 and 93% O2 mixture
for five minutes or until an end-tidal CO2 pressure
(PetCO2) of 70 mm Hg is reached or until exhaustion.
Data will be collected using a spirometer. The slope of
ventilatory response to carbon dioxide will be obtained
from a linear regression between ventilation and
PetCO2. The data will be adjusted by a 0.9 correction
factor to correct flow readings for hyperoxic gas mix-
ture. The rebreathing tests will be carried out at Santa
Casa de Misericordia Hospital (Sao Paulo, Brazil). All
manoeuvres will be carried out by physicians.
Epworth Sleepiness Scale The Epworth Sleep Scale is a
simple, self-administered questionnaire with items
addressing situations of daily activities and the occur-
rence of daytime sleepiness in adults. The subjects will
be instructed to classify their likelihood of feeling the
desire to nap or sleep in eight situations on a scale of 0
to 3 (0 = no chance of napping; 1 = small chancing of
napping; 2 = moderate chance of napping; and 3 =
strong chance of napping) [45,46].
Berlin Questionnaire The Berlin Questionnaire is used
to identify patients at high risk for sleep disordered
breathing in a variety of populations. This clinical his-
tory questionnaire has recognized efficacy in distinguish-
ing individuals at greater risk for OSA, with ten items
organized into three categories: snoring and apnoea (5
items), daytime sleepiness (4 items), systemic arterial
hypertension and obesity (1 item). Any marked response
is considered positive. The score is divided into cate-
gories. Category 1 is considered positive when there are
two or more positive responses to Items 1 to 5. Cate-
gory 2 is considered positive when there are two or
more positive responses to Items 6 to 8. Category 3 is
considered positive when the response to Item 9 is “yes”
or at BMI equal to or greater than 30 kg/m
2.T w oo r
more positive categories indicate high risk [47].
Polysomnography A complete full-night PSG will be
performed using a digital system (Embla, A10 version
3.1.2 Flaga, Hs. Medical Devices, Iceland) at the Sleep
Laboratory of Universidade Nove de Julho. All recording
sensors will be attached to the patient in a non-invasive
manner using tape or elastic bands. The following phy-
siological variables will be monitored simultaneously
and continuously: four channels for the electroencepha-
logram (EEG) (C3-A2, C4-A1, O1-A2, O2-A1), two
channels for the electrooculogram (EOG) (EOG-Left-
A2, EOG-Right-A1), four channels for the surface elec-
tromyogram (muscles of the submentonian region, ante-
rior tibialis muscle, masseter region and seventh
intercostal space), one channel for an electrocardiogram
(derivation V1 modified), airflow detection via two chan-
nels through a thermocouple (one channel) and nasal
pressure (one channel), respiratory effort of the thorax
(one channel) and the abdomen (one channel) via x-
trace belts, snoring (one channel) and body position
(one channel) via EMBLA sensors, and arterial oxygen
saturation (SaO2) and pulse rate via an EMBLA oxi-
meter. All PSGs will be performed and sleep stages
visually scored according to standardized criteria for
investigating sleep [48,49]. EEG arousals, sleep-related
respiratory events and leg movements will be scored in
accordance with the criteria established by the American
Academy of Sleep Medicine Manual for Scoring Sleep
and Associated Events [50].
The patients will be instructed to remain as relaxed as
possible and sleep naturally, as if at home. All signals
will be recorded continuously. Throughout the night,
the subjects will be monitored by a technician experi-
enced in polysomnography [49].
Bariatric surgery
Bariatric surgery will be performed on the subjects
selected for the procedure at the Santa Casa de Miseri-
córdia Hospital by experienced specialists. The surgical
techniques employed for the treatment of obesity are
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aim of restrictive techniques (vertical gastroplasty with
banding or Mason’s surgery, adjustable gastric band) is
to reduce gastric capacity in order to promote early sati-
ety, thereby reducing the volume of food ingested. The
aim of malabsorptive techniques (jejunoileal bypass or
Payne’s operation) is to reduce the absorption of foods
through the exclusion of a segment of small intestine.
Mixed techniques [Fobi-Capella surgery, Scopinaro’s
biliopancreatic diversion, and a Scopinaro technique
modified by Marceau and Biron (duodenal-switch)]
combine mechanical restriction to the food bolus and
intestinal malabsorption [51,52].
Bariatric Analysis and Reporting Outcome System (Baros)
The Bariatric Analysis and Reporting Outcome System
(BAROS) introduced by Oria and Moorhead in 1997 [53]
provides a standard for comparisons of surgical treatment
in patients with morbid obesity. This system adds or sub-
tracts points in the evaluation of three main areas (percen-
tage of excess weight loss, changes in medical conditions
and assessment of quality-of-life), considering four out-
come groups (failure, fair, good and excellent). Points are
deducted for complications and reoperative surgery. The
comorbidities taken into account by BAROS are hyperten-
sion, cardiovascular disease, dyslipidemia, type 2 diabetes,
sleep apnoea syndrome, osteoarthritis and infertility. Idio-
pathic intracranial hypertension, lower extremity venous
stasis disease, gastroesophageal reflux and urinary stress
incontinence become comorbidities when these conditions
impair or diminish quality of life or require long-tem
treatment [54].
Quality control
In order to ensure data quality, the physiotherapists and
physicians in charge of the data acquisition in this study
will receive specific training. Periodic external monitor-
ing will be performed to verify the adequate application
of the methodology in collecting information and per-
forming the different examinations. The results of the
preoperative and postoperative exams will be analysed
by blinded evaluators.
Statistical analysis
Data will be presented as means ± standard deviation,
when applicable. For comparison of continuous variables
before and after bariatric surgery, it will be used the
paired Student t-test or Wilcoxon tests as appropriate.
Comparisons between groups will be performed using
Student t test or Mann-Whitney U according to the
distribution.
All tests will be 2 tailed, and p values of less than 0.05
will be assumed to represent statistical significance.
Multivariate linear regression will be used to identify
independent predictors of the AHI following surgical
weight loss. All analyses will be done using SPSS ver.
16.0 [55].
Discussion
Obesity is a chronic and often a life-long disease. It is a
major cause of preventable death and is associated with
a range of negative physiological and psychological con-
sequences [56]. The aim of this study is to analyse clini-
cal parameters referring to anthropometric data,
pulmonary function tests, respiratory mechanics, sleep
study, sleepiness scale and chemosensitive response to
CO2 in patients with morbid obesity submitted to baria-
tric surgery. If successful, this project will help reduce
the negative health, economic and social consequences
of obesity.
Acknowledgements
The Sleep Laboratory receives funding from the Nove de Julho University
(Brazil) and research projects approved by the Brazilian fostering agency
Conselho Nacional de Desenvolvimento Científico e Tecnológico (Domestic
Grants/Universal Notice MCT/CNPQ14/2008, process N° 481169/2008-3) and
Fundaçao de Amparo a Pesquisa do Estado de Sao Paulo (local acronym
FAPESP) (protocol number 2003/01810-4). LVFO receive grant from the
Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (local acronym
CNPq) (Research Productivity modality - PQID, process number 307618/2010-
2).
Author details
1Master’s and Doctoral Degree Program in Rehabilitation Sciences, Nove de
Julho University, Sao Paulo, Brazil.
2Sleep Laboratory, Nove de Julho
University, Sao Paulo, Brazil.
3School of Medicine, Fortaleza University,
Fortaleza, Ceara, Brazil.
4Psychology Service, Santa Casa de Misericórdia
Hospital, Sao Paulo, Brazil.
5Surgery Department, Santa Casa de Misericórdia
Hospital, Sao Paulo, Brazil.
Authors’ contributions
All the authors contributed to the conception and design the study. LVFO
and ICA provided the idea for the study, established the hypothesis and
wrote the original proposal. ICA and LVFO significantly contributed to
writing this paper, while LCG, LMMS, LAP, CSO, FSSLF, RPH, ISR, CAM, WRFJ
and NSFJ were involved in critically revising the manuscript. This protocol
paper was written by ICA and LVFO with input from all co-authors. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 2 August 2011 Accepted: 17 October 2011
Published: 17 October 2011
References
1. World Health Organization Obesity and overweight. Fact Sheet No 311.
[http://www.who.int/mediacentre/factsheets/fs311/en/index.html], Updated
Sep 2006. Accessed 2011 May 18. .
2. Xavier MAF, Ceneviva R, Terra Filho J, Sankarankutty AK: Pulmonary
function and quality of life in patients with morbid obesity six months
after bariatric surgery. Acta cirurgica brasileira 2010, 25(5):407-415.
3. Zammit C, Liddicoat H, Moonsie I, Makker H: Obesity and respiratory
disease. International Journal of General Medicine 2010, 3:335-343.
Oliveira et al. BMC Surgery 2011, 11:28
http://www.biomedcentral.com/1471-2482/11/28
Page 6 of 84. Clinical Guidelines on the Identification, Evaluation, and Treatment of
Overweight and Obesity in Adults: The Evidence Report: National
Institutes of Health. Obes Res 1998, , Suppl 2: 51S-209S.
5. Nieto FJ, Young TB, Lind E, Samet JM, Redline S, D’Agostinho RB,
Newman AB, Lebowitz MD, Pickering TG: Association of sleepdisordered
breathing, sleep apnea and hypertension in a large community-based
study: Sleep Heart Health Study. JAMA 2000, 12(283):1829-1836.
6. Drager LF, Bortolotto LA, Krieger EM, Lorenzi-Filho G: Additive Effects of
Obstructive Sleep Apnea and Hypertension on Early Markers of Carotid
Atherosclerosis. Hipertension 2008, 53:64-69.
7. Kanaley JA, Goulopoulou SH, Franklin RM, Baynard T, Holmstrup ME,
Carhart R Jr, Weinstock RS, Fernahall B: Plasticity of heart rate signaling
and complexity with exercise training in obese individuals with and
without type 2 diabetes. In J Obes (Lond) 2009, 33(10):1198-206.
8. Young T, Peppard PE, Taheri S: Excess weight and sleep-disordered
breathing. J Appl Physiol 2005, 99:1592-1599.
9. Beyerlein A, Von Kries R, Ness AR, Ong KK: Genetic markers of obesity risk:
strong associations with body composition in overweight compared to
normal-weight children. Plos one 2011, 6(4):19057.
10. Alan I, Lewis MJ, Lewis KE, Stephens JW, Baxter JN: Influence of bariatric
surgery on indices of cardiac autonomic control. Autonomic Neuroscience:
Basic and Clinical 2009, 151:168-173.
11. Peker Y, Hedner J, Kraiczi H, Loth S: Respiratory disturbance index: an
independent predictor of mortality in coronary artery disease. Am J
Respir Crit Care Med 2000, 162:81-86.
12. Lazarus R, Sparrow D, Weiss TS: Effects of Obesity and Fat Distribution on
Ventilatory Function: the normative aging study. Chest 1997, 111:891-98.
13. Blake C, Fabick KM, Seychell KDR, Lund TD, Lephart ED: Neuromodulation
by soy dietsor equol: Anti-depressive e anti-obesity-like influences, age
e hormone-dependent effects. BMC neurosciences 2011, 12(28):1471-2202.
14. Stephen W, Littleton MD, Babak M: The Pickwickian Syndrome - Obesity
Hipoventilation Syndrome. Clin Chest Med 2009, 30:467-478.
15. Berger KI, Ayappa I, Chart-amontri B, Marfatia A, Sorkin IB, Rapoport DM,
Goldring RM: Obesity Hypoventilation Syndrome as a Spectrum of
Respiratory Disturbances During Sleep. Chest 2001, 120(4):1231-1238.
16. Weitzenblum E, Kessler R, Chaouat A: Alveolar hypoventilation in the
obese: the obesity-hypoventilation syndrome. Rev Pneumol Clin 2002,
58(2):83-90.
17. Sleep-related breathing disorders in adults: recommendations for
syndrome definition and measurement techniques in clinical research.
The Report of an American Academy of Sleep Medicine Task Force.
Sleep 1999, 22:667-689.
18. Feinsilver SH: Current and future methodology for monitoring sleep.
Clinics in Chest Medicine 1998, 19(1):213-18.
19. Bard MS: Pathophysiology of upper airway obstruction durion sleep.
Clinics in Chest Medicine 1998, 9(1).
20. Bruwell CS, Robin ED, Whaley RD: Extreme obesity associated with
alveolar hipoventilation: a pickwickian syndrome. American Journal
Medicine 1956, 21:811-818.
21. Namyslowski G, Scierski W, Mirowka-kata K, Kawecka I, Kawecki D, Czecior E:
Sleep Study in Patients With Overweight and Obesity. Jornal of
Physiology and Pharmacology 2005, 56(6):59-65.
22. Matlhota A, White DP: Obstructive sleep apnea. The Lancet 2002,
360(20):237-45.
23. Sue DY: Obesity and Pulmonary Function. Chest 1997, 111:844-45.
24. Poirier P, Giles TD, Bray GA, Hong Y, Stern J, Pi-Sunyer FX, Eckel RH: Obesity
and cardiovascular Disease: Pathophysiology, Evaluation and Effect of
Weight Loss. Circulation 2006, 113:898-918.
25. Buchwald H: Consensus conference statement bariatric surgery for
morbid obesity: health implications for patients health profissionals and
third-party payers. Surgery for obesity and related diseases 2005, 1(3):371-81.
26. Yanovski SZ, Yanoviski JA: Obesity. N Engl J Med 2002, 346(8):591-602.
27. Ceneviva R, Silva GA, Veigas MM, Sankarankutty AK, Chueire FB: Cirurgia
bariátrica e apnéia do sono. Rev Hosp Clin Fac Med Univ São Paulo 2006,
39(2):235.
28. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K:
Bariatric Surgery A systematic review and meta-analysis. JAMA 2004,
292(14):1724-1737.
29. Surgical Management of Morbid Obesity. Curr Probl Surg 2008, 45:68-137.
30. Zilberstein B, Galvão NM, Ramos AC: The surgery in the obesity treatment.
Revista Brasileira de Medicina 2002, 59(4):258-64.
31. Littieri CJ, Eliasson AH, Greenburg DL: Persistence of obstructive apnea
after surgical weight loss. J Clin Sleep Med 2008, 4(4):333-338.
32. Punjabi NM: The epidemiology of adult obstructive sleep apnea. Proc Am
Thorac Soc 2008, 5:136-143.
33. Dement WC: The study of human sleep: a historical perspective. Thorax
1998, 53(3):2-7.
34. Liistro G, Rombaux PH, Belge C, Dury M, Aubert G, Rodenstein DO: High
mallampati score and nasal obstruction are associated risk factors for
obstructive sleep apnoea. Eur Respir J 2003, 21:248-252.
35. Nakata S, Noda A, Yanagi E, Suzuki K, Yamamoto H, Nakashima T: Tonsil
size and body index are importante factors for efficacy of simple
tonsillectomy in obstructive apnoea syndrome. Clinical Otolaryngology
2006, 31:41-45.
36. Silva RS, Tufik S, Conway SG, Taddei JA, Bittencourt LRA: Sao Paulo
epidemiologic study: rationale, design, sampling, and procedures. Sleep
Medicine 2008, 10:679-685.
37. Moorehead MK, Ardelt-Gattinger E, Lechner H, Oria HE: The validation of
Moorehead - Ardelt quality of life questionnaire II. Obesity Surgery 2003,
13:684-692.
38. Heyward VH: Advanced fitness assessment & exercise prescription.
Champaign: Human Kinetics; 2006.
39. Gabrielsen AM, Lund MB, Kongerud J, Viken KE, Roislien J, Hjelmesaeth J:
The relationship between anthropometric measures, blood gases and
ling function in morbidly obese white subjects. Obes Surg 2011,
21:485-491.
40. Costa D, Sampaio LMM, Lorenzzo VAP, Jamami M, Damaso AR: Avaliação
da força muscular respiratória e amplitudes torácicas e abdominais após
a RFR em indivíduos obesos. Rev Latino-Am Enfermagem 2003, 1(2):156-60.
41. Pereira CAC: II Consenso Brasileiro de Espirometria. J Pneumol 2002, 28(3):
S1-S82.
42. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC:
Lung volumes and forced ventilatory flows. Report Working Party
Standardization of Lung Function Tests, European Community for Steel
and Coal. Official Statement of the European Respiratory Society. Eur
Respir J Suppl 1994, 7(6):1197-8.
43. Magnani KL, Cataneo AJM: Respiratory muscle strength in obese
individuals and influence of upper-body fat distribution. Med J 2007,
125(4):215-219.
44. Read DJC: A clinical method for assessing the ventilatory response to
carbon dioxide. Australas Ann Med 1967, 16(1):20-32.
45. Murray WJ: A new method for measuring daytime sleepiness: the
Epworth sleepiness scale. leep 1991, 14(6):540-545.
46. Murray WJ: Reliability and factor analysis of Epowoth sleepiness scale.
Sleep 1992, 15(4):376-81.
47. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP: Using the Berlin
Questionnaire to identify patients at risk for the sleep apnea syndrome.
Ann Intern Med 1999, 131(7):485-491.
48. Rechtschaffen A, Kales A: A manual of standardized terminology:
techniques and scoring system for sleep stages of human subjects. In
Psychiatry and Clinical Neurosciences. Volume 55. Los Angeles: Brain
Information Service/Brain Research Institute; 1968; 2001:305-310.
49. Iber C, Ancoli-Israel S, Chesson A Jr, Quan S: The AASM manual for the
scoring of sleep and associated events: rules, terminology and technical
specifications. Westchester: merican Academy of Sleep Medicine; 2007.
50. American Academy of Sleep Medicine. The AASM Manual for the
scoring of sleep and associated events. Rules, terminology and technical
especifications 2007.
51. Sundson M, Gustavsson S: Bariatric surgery. Clinics in dermatology 2004,
22:325-331.
52. Karmali S, Stoklissa CJ, Sharma A, Stadnyk J, Christiansen S, Cottreau D, et al:
Bariatric surgery. Canadian Family Physician 2010, 56:873-879.
53. Favretti F, Cadiere GB, Segato G, Busetto L, Loffredo A, Vertruyen M, Enzi G,
Ciniato D, De Marchi F, Lise M: Bariatric Analysis and reporting outcome
system (BAROS) applied to laparoscopic gastric banding patients. Obesity
Surgery 1998, 8:500-504.
54. Oria HE, Moorehead MK: Updated Bariatric Analysis and Reporting Outcome
System (BAROS). Surgery for obesity and relate diseases 2009, 5:60-66.
Oliveira et al. BMC Surgery 2011, 11:28
http://www.biomedcentral.com/1471-2482/11/28
Page 7 of 855. Kleinbaum DG, Kupper LL, Morgestern H: Epidemiologic research
Reinhold. Van Nostram 1983.
56. Pijl H: Obesity: evolution of symptom of affluence. The Jornal of Medicine
2011, 69(4):159-166.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2482/11/28/prepub
doi:10.1186/1471-2482-11-28
Cite this article as: Oliveira et al.: Sleep study, respiratory mechanics,
chemosensitive response and quality of life in morbidly obese patients
undergoing bariatric surgery: a prospective, randomized, controlled
trial. BMC Surgery 2011 11:28.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Oliveira et al. BMC Surgery 2011, 11:28
http://www.biomedcentral.com/1471-2482/11/28
Page 8 of 8